Try our Advanced Search for more refined results

Glenmark Can't Start Selling MS Drug Amid Biogen Fight

By Hanna Vioque ( July 29, 2025, 12:44 AM BST) -- Glenmark has failed to shake off a sales ban and a $1 million fine over its multiple sclerosis treatment after a Swedish appellate court ruled that it couldn't market the generic version as long as Biogen's patent for its blockbuster drug Tecfidera was still in force. ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies